Exponent, Inc.  

(Public, NASDAQ:EXPO)   Watch this stock  
Find more results for EXPO
57.78
-0.71 (-1.21%)
Jun 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 57.41 - 58.62
52 week 47.17 - 58.92
Open 58.31
Vol / Avg. 27,487.00/31,530.00
Mkt cap 761.84M
P/E 22.25
Div/yield 0.15/1.04
EPS 2.60
Shares 13.19M
Beta 0.62
Inst. own 90%
Jul 23, 2013
Q2 2013 Exponent Earnings Conference Call Add to calendar
Jul 23, 2013
Q2 2013 Exponent Earnings Release Add to calendar
Jun 13, 2013
Exponent at William Blair Growth Stock Conference
May 30, 2013
Exponent Annual Shareholder Meeting
Apr 17, 2013
Q1 2013 Exponent Earnings Conference Call
Apr 17, 2013
Q1 2013 Exponent Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 10.98% 12.72%
Operating margin 14.93% 19.69%
EBITD margin - 21.30%
Return on average assets 10.48% 12.74%
Return on average equity 14.72% 18.47%
Employees 960 -
Carbon Disclosure Rating - -

Address

149 COMMONWEALTH DRIVE
MENLO PARK, CA 94025
United States - Map
+1-650-3269400 (Phone)
+1-650-3268072 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Exponent, Inc. is a science and engineering consulting firm that provides solutions to complex problems. The Company�s services include analysis of products, people, property, processes and finances related to litigation, product recall, regulatory compliance, research, development and design. It operates in two segments. One operating segment is a broad service group providing technical consulting in different practices primarily in the areas of engineering and technology development. Its other operating segment provides services in the area of environmental, epidemiology and health risk analysis. This operating segment provides a range of consulting services relating to environmental hazards and risks and the impact on both human health and the environment. It serves clients in automotive, aviation, chemical, construction, consumer products, energy, government, health, insurance, manufacturing, technology and other sectors.

Officers and directors

Paul R. Johnston Ph.D. President, Chief Executive Officer, Director
Age: 59
Bio & Compensation  - Reuters
Richard L. Schlenker Jr. Chief Financial Officer, Executive Vice President, Corporate Secretary
Age: 47
Bio & Compensation  - Reuters
Subbaiah V. Malladi Ph.D. Chief Technical Officer
Age: 66
Bio & Compensation  - Reuters
Elizabeth L. Anderson Ph.D. Group Vice President
Age: 72
Bio & Compensation  - Reuters
Paul D. Boehm Ph.D. Group Vice President
Age: 64
Bio & Compensation  - Reuters
Robert D. Caligiuri Ph.D. Group Vice President
Age: 61
Bio & Compensation  - Reuters
Catherine Ford Corrigan Ph.D., Group Vice President
Age: 44
Bio & Compensation  - Reuters
John E. Moalli Group Vice President
Age: 48
Bio & Compensation  - Reuters
John D. Osteraas Ph.D. Group Vice President
Age: 58
Bio & Compensation  - Reuters
Michael R. Gaulke Chairman of the Board
Age: 67
Bio & Compensation  - Reuters